Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Change in Account Payables: 2012-2025

Historic Change in Account Payables for Mimedx Group (MDXG) over the last 14 years, with Sep 2025 value amounting to $2.9 million.

  • Mimedx Group's Change in Account Payables rose 378.76% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 314.88%. This contributed to the annual value of -$1.4 million for FY2024, which is 280.08% down from last year.
  • Per Mimedx Group's latest filing, its Change in Account Payables stood at $2.9 million for Q3 2025, which was up 536.08% from -$668,000 recorded in Q2 2025.
  • Over the past 5 years, Mimedx Group's Change in Account Payables peaked at $3.7 million during Q2 2021, and registered a low of -$3.6 million during Q3 2021.
  • Over the past 3 years, Mimedx Group's median Change in Account Payables value was $283,000 (recorded in 2024), while the average stood at $279,818.
  • Per our database at Business Quant, Mimedx Group's Change in Account Payables spiked by 6,878.57% in 2023 and then crashed by 330.68% in 2024.
  • Quarterly analysis of 5 years shows Mimedx Group's Change in Account Payables stood at $669,000 in 2021, then tumbled by 137.52% to -$251,000 in 2022, then spiked by 126.69% to $67,000 in 2023, then soared by 964.18% to $713,000 in 2024, then surged by 378.76% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q3 2025, -$668,000 for Q2 2025, and $1.5 million during Q1 2025.